Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Development and clinical utility of abiraterone acetate as an androgen synthesis inhibitor
A. Bryce
, C. J. Ryan
Hematology/Oncology
Research output
:
Contribution to journal
›
Review article
›
peer-review
48
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Development and clinical utility of abiraterone acetate as an androgen synthesis inhibitor'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Steroid Synthesis Inhibitors
100%
Abiraterone Acetate
90%
Androgen Receptors
30%
Prostatic Neoplasms
22%
Castration
15%
United States Food and Drug Administration
14%
Drug Therapy
8%
Therapeutics
4%